Skip to main content
. 2021 Apr 13;11:8021. doi: 10.1038/s41598-021-87535-x

Table 3.

Detailed follow-up data of 4 mothers and 4 infants.

Case1 Case2 Case3 Case4
Date of COVID-19 onset 20th Jan 31th Jan 15th Feb 8th Feb
GA at onset of COVID-19 (weeks) 36+5 37+1 35+5 28+2
Date of delivery 16th Feb 16th Feb 3rd Mar 5th Mar
GA at delivery (weeks) 37+4 39+3 38+2 32
Date of 1st Ab detection 16th Feb 16th Feb 3rd Mar 5th Mar
Delivery mode Cesarean Cesarean Cesarean Cesarean
Maternal 1st IgM (s/co) 1.56 23.6 0.56 8.4
Maternal 1st IgG (s/co) 7.01 11.74 12.06 13.67
Infantile 1st IgM (s/co) 0.1 0.15 0.38 0.2
Infantile 1st IgG (s/co) 5.14 11.39 7.55 12.55
Date of 2nd Ab detection 19th Apr 19th Apr 19th Apr 21th Apr
Days between 1st to 2nd Ab detection (days) 63 63 47 47
Maternal 2nd IgM (s/co) 6.38 34.51 1.48 21.11
Maternal 2nd IgG (s/co) 1.92 15.93 6.18 9.25
Infantile 2nd IgM (s/co) 0.07 0.08 0.06 0.15
Infantile 2nd IgG (s/co) 0.5 1.21 1.01 1.2
Infantile 1st IgG/Maternal 1st IgG (%) 73.32% 97.02% 62.60% 91.81%
Infantile 2nd IgG/Maternal 2nd IgG (%) 26.04% 7.60% 16.34% 12.97%

GA gestational age, Ab antibody.